No profile data available.
Revvity, Inc. (RVTY) is a healthcare company in the biological analysis equipment industry, based in Waltham, United States, with about 11,000 full-time employees.
It reported revenue of $2.86 billion for fiscal year 2025, up 3.7% from fiscal year 2024, and net income of $241.20 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $729.69 million, up 1.3% from a year before. Its largest business segment, Life Sciences, brought in 50% of segment revenue in fiscal year 2025; U.S. was the largest region with 39%. Its market capitalization was $17.20 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Revvity, Inc. provides health sciences solutions, technologies, and services.
Revvity reported $2.86 billion in revenue for fiscal year 2025, up 3.7% from $2.76 billion in fiscal year 2024. In Q2 2026 revenue was $729.69 million.
Life Sciences, with $1.43 billion or 50% of segment revenue in fiscal year 2025. Next: Diagnostics (50%).
U.S.: 39% of revenue by region in fiscal year 2025, followed by Other International (35%).
$17.20 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include Agilent Technologies, Inc. (A), Illumina, Inc. (ILMN), Mettler-Toledo International Inc. (MTD), Bio-Techne Corporation (TECH).